CREBBP and prostate cancer: However, we show that p300/CBP deposit H2BNTac independently of their bromodomain, aligning with prior reports that bromodomain inhibition does not dislodge p300 from chromatin24,75 and fails to extinguish its oncogenic gene programs in prostate cancer cells.